SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-21-000829
Filing Date
2021-05-13
Accepted
2021-05-13 16:29:50
Documents
39
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q e2736_10-q.htm 10-Q 354006
2 EX-31 e2736_ex31-1.htm EX-31 8613
3 EX-31 e2736_ex31-2.htm EX-31 8709
4 EX-32 e2736_ex32-1.htm EX-32 6964
5 GRAPHIC e2736_10-qimg001.jpg GRAPHIC 154857
6 GRAPHIC e2736_10-qimg002.jpg GRAPHIC 74829
  Complete submission text file 0001731122-21-000829.txt   1986303

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE avxl-20210331.xml EX-101.INS 224641
8 XBRL SCHEMA FILE avxl-20210331.xsd EX-101.SCH 19958
9 XBRL CALCULATION FILE avxl-20210331_cal.xml EX-101.CAL 25587
10 XBRL DEFINITION FILE avxl-20210331_def.xml EX-101.DEF 68405
11 XBRL LABEL FILE avxl-20210331_lab.xml EX-101.LAB 158182
12 XBRL PRESENTATION FILE avxl-20210331_pre.xml EX-101.PRE 119098
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 21920081
SIC: 8731 Services-Commercial Physical & Biological Research